[go: up one dir, main page]

DK1037629T3 - Kombination af et retinsyremetabolismeblokerende middel og en tocopherol - Google Patents

Kombination af et retinsyremetabolismeblokerende middel og en tocopherol

Info

Publication number
DK1037629T3
DK1037629T3 DK98966615T DK98966615T DK1037629T3 DK 1037629 T3 DK1037629 T3 DK 1037629T3 DK 98966615 T DK98966615 T DK 98966615T DK 98966615 T DK98966615 T DK 98966615T DK 1037629 T3 DK1037629 T3 DK 1037629T3
Authority
DK
Denmark
Prior art keywords
tocopherol
combination
retinoic acid
blocking agent
acid metabolism
Prior art date
Application number
DK98966615T
Other languages
English (en)
Inventor
Porre Peter Marie-Zoe Rober De
Jan Paul Jozef Mich Bruynseels
Walter Boudewijn Leopo Wouters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK1037629T3 publication Critical patent/DK1037629T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98966615T 1997-12-19 1998-12-12 Kombination af et retinsyremetabolismeblokerende middel og en tocopherol DK1037629T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97204019 1997-12-19
EP98966615A EP1037629B1 (en) 1997-12-19 1998-12-12 Combination of a retinoic acid metabolism blocking agent and a tocophereol
PCT/EP1998/008127 WO1999032098A2 (en) 1997-12-19 1998-12-12 Combination of a ramba and a tocopherol

Publications (1)

Publication Number Publication Date
DK1037629T3 true DK1037629T3 (da) 2005-03-07

Family

ID=8229088

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98966615T DK1037629T3 (da) 1997-12-19 1998-12-12 Kombination af et retinsyremetabolismeblokerende middel og en tocopherol

Country Status (11)

Country Link
US (1) US6265425B1 (da)
EP (1) EP1037629B1 (da)
JP (1) JP2001526215A (da)
AT (1) ATE280578T1 (da)
AU (1) AU2413399A (da)
DE (1) DE69827295T2 (da)
DK (1) DK1037629T3 (da)
ES (1) ES2232034T3 (da)
PT (1) PT1037629E (da)
SI (1) SI1037629T1 (da)
WO (1) WO1999032098A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7636680B2 (en) * 2001-10-03 2009-12-22 Starmine Corporation Methods and systems for measuring performance of a security analyst
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
WO2006074147A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
NZ544472A (en) 2003-07-03 2009-04-30 Myriad Genetics Inc Compounds and therapeutical use thereof
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
WO2006028970A1 (en) 2004-09-02 2006-03-16 Cengent Therapeutics, Inc. Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CN101400261B (zh) 2006-01-17 2013-07-10 斯蒂菲尔实验室公司 使用三唑化合物治疗炎症异常
EP1991530A1 (en) * 2006-02-21 2008-11-19 Amgen Inc. Cinnoline derivatives as phosphodiesterase 10 inhibitors
EP2491928A2 (en) * 2007-10-19 2012-08-29 The University of Tokyo Therapeutic agent for vitiligo and method of accelerating pigmentation

Also Published As

Publication number Publication date
WO1999032098A3 (en) 1999-08-19
EP1037629A2 (en) 2000-09-27
SI1037629T1 (en) 2005-04-30
JP2001526215A (ja) 2001-12-18
AU2413399A (en) 1999-07-12
ATE280578T1 (de) 2004-11-15
DE69827295T2 (de) 2006-02-09
ES2232034T3 (es) 2005-05-16
US6265425B1 (en) 2001-07-24
DE69827295D1 (de) 2004-12-02
WO1999032098A2 (en) 1999-07-01
EP1037629B1 (en) 2004-10-27
PT1037629E (pt) 2005-03-31

Similar Documents

Publication Publication Date Title
DK1037629T3 (da) Kombination af et retinsyremetabolismeblokerende middel og en tocopherol
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
DK0650483T3 (da) (3R,4R)-Delta6-tetrahydrocannabinol-7-syrer
EP2261200A3 (en) Modified forms of pharmacacologically active agents and uses therefor
SE9703693D0 (sv) Novel combination
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
IS2750B (is) Leiðarafesting
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
IT1285770B1 (it) Composti corticoidei
BR0013935A (pt) IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos
ATE258797T1 (de) Verwendung von amifostin
DE60128100D1 (de) Analgetisches arzneimittel
AU2002332488A8 (en) R-bambuterol, its preparation and therapeutic uses
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
NO20012351L (no) Farmasoytisk sammensetning for modifisert frigjoring av insulinsensibiliserende middel
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
SE9800905L (sv) Ny terapi vid glomerulonefrit
NO20023111L (no) Utvortes preparat for behandling av pruritus
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet